Non-Invasive Blood Glucose Monitoring Devices Market, By Technology (EM Waves, Transdermal, Optical, and Enzymatic), By Modality (Wearable, Non-Wearable/Benchtop, and Embedded Devices), By End User (Hospitals, Clinics, and Homecare Setting), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa).

Published In : Feb 2024

Code : CMI1480

Pages :163

Formats :

Excel and PDF

Industry : Medical Devices

Regional Analysis

Global Non-Invasive Blood Glucose Monitoring Devices Market Regional Insights

North America is the largest market for non-invasive blood glucose monitoring devices, accounting for 35% of the global market share for the year 2023. The high prevalence of diabetes in the region is driving the growth of the market.
Europe is the second largest market for non-invasive blood glucose monitoring devices, accounting for 25% of the global market share for the year 2023. The increasing awareness in the region is driving the market for the forecasted period of time
Asia Pacific is the third largest market for non-invasive blood glucose monitoring devices, accounting for 20% of the global market share for the year 2023. The rising incidence of heart diseases and lifestyle related diseases such as diabetes in the region are driving the growth of the market.

Figure 1. Global Non-Invasive Blood Glucose Monitoring Devices Market Share (%), by Region, 2023

Geographies covered:

North America: U.S. and Canada
Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
Middle East: GCC Countries, Israel, and Rest of Middle East
Africa: South Africa, North Africa, and Central Africa